ScholarIQanswers from OpenAlex & ORCID
Marcus O. Butler
ResearcherPublications, citations & collaboration network
Marcus O. Butler is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marcus O. Butler have?
ScholarIQindexed works
Marcus O. Butler has 563 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marcus O. Butler have?
ScholarIQcitation count
Marcus O. Butler has 17,135 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marcus O. Butler?
ScholarIQh-index
Marcus O. Butler has an h-index of 60 in OpenAlex.
What is the i10-index of Marcus O. Butler?
ScholarIQi10-index
Marcus O. Butler has an i10-index of 163 in OpenAlex.
What is the ORCID of Marcus O. Butler?
ScholarIQorcid
The ORCID for Marcus O. Butler is on the source record.
What is the OpenAlex record for Marcus O. Butler?
ScholarIQopenalex
The OpenAlex for Marcus O. Butler is on the source record.
What are the most-cited papers on Marcus O. Butler?
ScholarIQmost cited works
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, Jean‐François Baurain, Marcus O. Butler, Max Schlaak, Ryan J. Sullivan, Sebastian Ochsenreither, Reinhard Dummer, John M. Kirkwood, Anthony M. Joshua, Joseph J. Sacco, Alexander N. Shoushtari, Marlana Orloff, Josep M. Piulats, Mohammed Milhem, April K.S. Salama, Brendan D. Curti, Lev Demidov, Lauris Gastaud, Cornelia Mauch, Melinda Yushak, Richard D. Carvajal, Omid Hamid, Shaad E. Abdullah, Chris Holland, Howard Goodall, Sophie Piperno‐Neumann
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Paolo A. Ascierto, Michele Del Vecchio, Mario Mandalà, Helen Gogas, Ana Arance, Stéphane Dalle, C. Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion‐Sileni, Iván Márquez‐Rodas, Marcus O. Butler, Michele Maio, Mark R. Middleton, Luis de la Cruz‐Merino, Petr Arenberger, Victoria Atkinson, Andrew Hill, Leslie A. Fecher, Michael Millward, Nikhil I. Khushalani, Paola Queirolo, Maurice Lobo, Veerle de Pril, John T. Loffredo, James Larkin, Jeffrey S. Weber
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski, Jean‐François Baurain, Max Schlaak, Marcus O. Butler, Ryan J. Sullivan, Reinhard Dummer, John M. Kirkwood, Marlana Orloff, Joseph J. Sacco, Sebastian Ochsenreither, Anthony M. Joshua, Lauris Gastaud, Brendan D. Curti, Josep M. Piulats, April K.S. Salama, Alexander N. Shoushtari, Lev Demidov, Mohammed Milhem, Bartosz Chmielowski, Kevin B. Kim, Richard D. Carvajal, Omid Hamid, Laura Collins, Koustubh Ranade, Chris Holland, Constance R. Pfeiffer, Paul Nathan